We regularly advise more than 100 listed companies in the U.S., Asia and Europe on corporate governance and sensitive securities law disclosure and compliance matters. Our governance advice amidst the COVID-19 pandemic has included the full gamut of activities, from preparedness to crisis management. We have advised on liquidity issues, activism preparedness and contingency planning for liability management and possible restructurings. We have securities law practitioners (including many former senior securities regulators) who are able to provide practical and forward-thinking advice on very difficult disclosure issues involving the pandemic.
